United States · Investor

PathoCapital

Last cheque observed Dec 2017. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

QuietGrowth equity

Series BSeries APrivate Social NetworkingSoftware

Cheques on record
0%of best year0cheques in 12 months, 3 on record
Since the last cheque3234days00hrs00min00sec
Median round$70MRounds led0 of 3Exits1 from the portfolio
Pitch PathoCapital

PathoCapital highlights

  1. 01

    3 rounds on record

  2. 02

    Mostly Series B and Series A: 100% of its rounds

  3. 03

    1 exits from the portfolio

What they do

Type
Growth equity (from a list, unverified)
Cheque size
Not stated
Sectors
Private Social NetworkingSoftware
Based in
United States
Cold pitches
Not stated

The record

Every round we can evidence, newest first3 appearances

  1. 2017

    1 round

  2. Dec
    AptinyxSeries B · US · FinSMEs$70MWith 15 others
  3. 2012

    1 round

  4. Dec
    NaurexSeries B · US · fiercebiotech.com$38MWith 6 others
  5. 2011

    1 round

  6. May
    NaurexSeries A · US · fiercebiotech.com$18MWith 5 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

Exits from the portfolio

Companies it backed that were later bought or listed1 in all

NaurexBought by Allergan$560MJul 2015

An exit counts when it came after the firm's first round in the company. From historical deal records.

Who they invest alongside

The investors most often in the same rounds as PathoCapital. A count of rooms they were both in, not a relationship either has claimed.

Adams Street PartnersVC firm3rounds togetherDruid BioVenturesInvestment firm2rounds togetherGenesys CapitalVC firm2rounds togetherLatterell Venture PartnersVC firm2rounds together

Recently backed

The latest companies PathoCapital put money into.

Aptinyx$70M · Dec 2017

Quick answers about PathoCapital

What does PathoCapital invest in?

PathoCapital invests most often at Series B and Series A (100% of the rounds on record), in sectors such as Private Social Networking and Software.

How active is PathoCapital?

3 investments on record, 0 of them in the last 12 months. The most recent was in Dec 2017.

What has PathoCapital invested in recently?

Its most recent investments on record: Aptinyx (Series B, Dec 2017).

How big are PathoCapital's cheques?

The median round it joins is $70M.

Is PathoCapital investing now?

No investments in the last 12 months; the latest was in Dec 2017.

Who does PathoCapital invest alongside?

Most often Adams Street Partners (3 rounds together), Druid BioVentures (2 rounds together) and Genesys Capital (2 rounds together).

What kind of investor is PathoCapital?

PathoCapital is a growth equity firm based in United States.

Where does this information on PathoCapital come from?

From 3 articles and filings naming it in a round, public registers and its own website, checked and rebuilt every night.

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it